Insider Transaction Report for Jonathan Peri
2026-08-14SEC Filing 3 (0002149660-26-000001)
This filing is an initial statement of beneficial ownership of securities filed by Jonathan Peri, a director at Citius Oncology, Inc. The report covers transactions up to August 10, 2026. According to the filing, Mr. Peri holds 0 shares of Common Stock, and this is a direct ownership. The filing was signed on August 14, 2026, with a power of attorney from Alexander M. Donaldson.
Ticker mentioned:CTOR
Source:Original SEC Document β